Accessibility Menu
Assertio logo

Assertio

(NASDAQ) ASRT

This security has been delisted. This page is retained for historical reference.

Assertio last closing stock price
MetricPriceDate
Last closeUSD 23.502026-06-15
Assertio stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.3%USD 23.432026-06-08
1 month+0.77%USD 23.322026-05-15
3 month+88%USD 12.502026-03-17
Year to date+159.1%USD 9.072025-12-31
1 year+147.93%USD 9.482025-06-13
3 year-73.8%USD 89.702023-06-16
5 year-8.91%USD 25.802021-06-16
Since inception-90.21%USD 240.001997-12-02

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

ASRT Financials

Key Financial Metrics (TTM)

Gross Margin

44.32%

Operating Margin

-22.27%

Net Income Margin

-34.94%

Return on Equity

-38.72%

Return on Capital

-12.86%

Return on Assets

-16.89%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$45.27M

Operating Income

-$22.75M

EBITDA

-$5.79M

Operating Cash Flow

-$7.08M

Capital Expenditure

$0.00

Free Cash Flow

-$7.08M

Cash & ST Invst.

$71.57M

Total Debt

$40.31M

Assertio Performance Analysis

Assertio annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 156,234,00040.7%
20232023-12-31USD 152,069,000-2.7%
20242024-12-31USD 124,961,000-17.8%
20252025-12-31USD 118,713,000-5.0%
Assertio sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3010.3%
Q32025-09-3069.3%
Q42025-12-31-72.6%
Q12026-03-31-26.7%
Assertio annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 30.08N/A
20232023-12-31USD -70.10N/A
20242024-12-31USD -3.40-95.2%
20252025-12-31USD -4.7439.6%
Assertio sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-21.4%
Q32025-09-30164.7%
Q42025-12-31-212.7%
Q12026-03-31-57.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$9.93M

-62.5%

Gross Profit

$1.38M

-85.3%

Gross Margin

13.91%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

58

N/A

Net Income

-$18.86M

-39.3%

EBITDA

-$12.20M

-273.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$71.57M

-18.0%

Total Debt

$40.31M

+0.1%

Accounts Receivable

$61.53M

-7.2%

Inventory

$23.01M

-41.6%

Long Term Debt

$40.09M

+0.3%

Short Term Debt

$220.00K

-26.2%

Return on Assets

-16.89%

N/A

Return on Invested Capital

-19.00%

N/A

Free Cash Flow

$8.56M

+168.3%

Operating Cash Flow

$8.56M

+168.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INCRInterCure Ltd.
$0.92-4.38%
NTRBNutriband Inc.
$3.11-0.64%
XBITXBiotech Inc.
$2.27-0.87%
FBIOFortress Biotech, Inc.
$3.36-1.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
INTCIntel
$95.04-0.02%
NOKNokia
$10.12-0.03%
PATHUiPath
$12.15+0.01%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.